Showing results (31-40 of 207) with videos related to
Sort By:
Pageof 21
European Review for Medical and Pharmacological Sciences|December 27, 2011
Emphysematous gastritis associated with ulcerative esophagitisS Hassan, K Abbass, R Markert, et al.Geburtshilfe Und Frauenheilkunde|June 21, 2019
Trastuzumab in the Treatment of Pregnant Breast Cancer Patients - an Overview of the LiteratureSophia S Goller, Udo R Markert, Karolin FröhlichAmerican Journal of Reproductive Immunology (New York, N.Y. : 1989)|June 24, 2004
Inhibition of HLA-G production in JEG-3 choriocarcinoma cells by RNA interferenceTobias Wengenmayer, Tobias G Poehlmann, Udo R MarkertImmunobiology|December 1, 2004
Immunology of human endometriumUlrike Kämmerer, Michael von Wolff, Udo R MarkertThe British Journal of Nutrition|July 2, 2008
Impact of PUFA on early immune and fetal developmentUta Enke, Lydia Seyfarth, Ekkehard Schleussner, et al.Cells|May 14, 2022
The Role of Non-Coding RNAs in the Human PlacentaMilena Žarković, Franziska Hufsky, Udo R Markert, et al.APMIS : Acta Pathologica, Microbiologica, Et Immunologica Scandinavica|April 18, 2018
Breast carcinoma in pregnancy with spheroid-like placental metastases-a case reportKarolin Froehlich, Hanne Stensheim, Udo R Markert, et al.Clinical and Experimental Obstetrics & Gynecology|February 13, 2002
Case report: successful pregnancy and delivery after myocardial infarction and essential thrombocythemia treated with clopidrogelP Klinzing, U R Markert, K Liesaus, et al.Gastrointestinal Endoscopy|August 1, 1996
Percutaneous endoscopic gastrostomy: a randomized prospective comparison of early and delayed feedingU Choudhry, C J Barde, R Markert, et al.American Journal of Reproductive Immunology (New York, N.Y. : 1989)|July 6, 2011
Reduction in miR-141 is induced by leukemia inhibitory factor and inhibits proliferation in choriocarcinoma cell line JEG-3Diana M Morales-Prieto, Ekkehard Schleussner, Udo R MarkertPageof 21